Breathing device could have profound impact on survival for people with sleep apnea and type 2 diabetes

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by around 26%, according to new research being presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD), Vienna (15–19 Sept).

Facebook Comments